Literature DB >> 5170924

Patient rejection of lithium carbonate prophylaxis.

P Polatin, R R Fieve.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5170924

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Clinical use of lithium in affective disorders.

Authors:  R R Fieve
Journal:  Drugs       Date:  1977-06       Impact factor: 9.546

Review 2.  Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs.

Authors:  L E Hollister
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 3.  Positive Traits in the Bipolar Spectrum: The Space between Madness and Genius.

Authors:  Tiffany A Greenwood
Journal:  Mol Neuropsychiatry       Date:  2016-12-09

Review 4.  Creativity and bipolar disorder: touched by fire or burning with questions?

Authors:  Sheri L Johnson; Greg Murray; Barbara Fredrickson; Eric A Youngstrom; Stephen Hinshaw; Julie Malbrancq Bass; Thilo Deckersbach; Jonathan Schooler; Ihsan Salloum
Journal:  Clin Psychol Rev       Date:  2011-10-13

5.  Long-term outcome of lithium prophylaxis in patients initially classified as complete responders.

Authors:  M Maj; R Pirozzi; D Kemali
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Positive Affect Enhances the Association of Hypomanic Personality and Cognitive Flexibility.

Authors:  Daniel Fulford; Greg Feldman; Benjamin A Tabak; Morgan McGillicuddy; Sheri L Johnson
Journal:  Int J Cogn Ther       Date:  2013-03-01

Review 7.  The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate.

Authors:  S C Dilsaver; A C Swann; A M Shoaib; T C Bowers
Journal:  J Psychiatry Neurosci       Date:  1993-03       Impact factor: 6.186

8.  Side effects of chronic lithium therapy in Hong Kong Chinese: an ethnopsychiatric perspective.

Authors:  S Lee
Journal:  Cult Med Psychiatry       Date:  1993-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.